WA
GILD icon

WFG Advisors’s Gilead Sciences GILD Stock Holding History

WFG Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-100
Closed -$4K – 2126
2014
Q2 		$4K Hold
100
– – ﹤0.01% 1699
2014
Q1 		$3K Buy
+100
New +$7.84K ﹤0.01% 1735

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WFG Advisors's GILD Position: Q2 2017 in Review

WFG Advisors increased its Gilead Sciences (GILD) stake by 42% in Q2 2017, buying an estimated $63.4K and bringing the position to 3,197 shares worth $226K. The position accounts for 0.05% of the portfolio, ranked #343.

WFG Advisors first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. The position peaked at $687K in Q4 2013. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • WFG Advisors held 3,197 shares of Gilead Sciences worth $226K as of Q2 2017.
  • WFG Advisors bought 953 Gilead Sciences shares in Q2 2017, an estimated $63.4K.
  • Gilead Sciences made up 0.05% of WFG Advisors's portfolio in Q2 2017, its #343 holding.
  • WFG Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
  • WFG Advisors's Gilead Sciences position peaked at $687K in Q4 2013.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.